Senseonics (SENS) Stock Price, News & Analysis

Company Overview

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Key Stats

• Today's Range: $0.65 to $0.69
• 50-Day Range: $0.52 to $0.87
• 52-Week Range: $0.25 to $1.40
• Volume: 1.65 million shs
• Average Volume: 6.34 million shs
• Market Capitalization: $451.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.00
• Consensus Rating: Strong Buy

Senseonics Stock Analysis - MarketRank™

Senseonics scored higher than 35% of companies evaluated by MarketBeat, and ranked 848th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Senseonics has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Senseonics has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Senseonics are expected to grow in the coming year, from ($0.14) to ($0.12) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Senseonics is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Senseonics is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Senseonics has a P/B Ratio of 9.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SENS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Senseonics does not currently pay a dividend.

Dividend Growth

Senseonics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for SENS.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.73

News Sentiment

Senseonics has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Senseonics this week, compared to 2 articles on an average week.

Search Interest

Only 9 people have searched for SENS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 3 people have added Senseonics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Senseonics insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.30% of the stock of Senseonics is held by insiders.

Percentage Held by Institutions

Only 12.36% of the stock of Senseonics is held by institutions.

SENS Stock Analysis - Frequently Asked Questions

How have SENS shares performed this year?

Senseonics' stock was trading at $0.5234 at the beginning of 2025. Since then, SENS stock has increased by 31.8% and is now trading at $0.69.
View the best growth stocks for 2025 here.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) announced its quarterly earnings data on Monday, March, 3rd. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.09. Senseonics had a negative net margin of 362.30% and a negative trailing twelve-month return on equity of 842.25%.

When did Senseonics IPO?

Senseonics (SENS) raised $45 million in an initial public offering (IPO) on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James served as the underwriters for the IPO and BTIG was co-manager.

Who are Senseonics' major shareholders?

Senseonics' top institutional investors include Ridgecrest Wealth Partners LLC (0.05%), Cambridge Investment Research Advisors Inc. (0.04%), Perkins Capital Management Inc. (0.01%) and Smith Salley Wealth Management (0.01%). Insiders that own company stock include Timothy T Goodnow, Mukul Jain, Frederick T Sullivan, Douglas A Roeder and Sharon Larkin.
View institutional ownership trends.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Senseonics investors own include Zomedica (ZOM), American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 3/03/2025
• Today: 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Process control instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NYSE:SENS
• Previous Symbol: NYSE:SENS
• CIK: 1616543
• Web: www.senseonics.com
• Phone: 301-515-7260
• Fax: 301-515-0988
• Employees: 90
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $2.00
• High Stock Price Target: $2.00
• Low Stock Price Target: $2.00
• Potential Upside/Downside: +189.9%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-60,390,000.00
• Net Margins: -362.30%
• Pretax Margin: -362.26%
• Return on Equity: -842.25%
• Return on Assets: -67.99%

Debt

• Debt-to-Equity Ratio: 59.17
• Current Ratio: 2.47
• Quick Ratio: 2.38

Sales & Book Value

• Annual Sales: $22.47 million
• Price / Sales: 20.09
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.07 per share
• Price / Book: 9.86

Miscellaneous

• Outstanding Shares: 654,216,000
• Free Float: 573,895,000
• Market Cap: $451.41 million
• Optionable: N/A
• Beta: 1.05